Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

155 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Supported exercise TrAining for Men wIth prostate caNcer on Androgen deprivation therapy (STAMINA): study protocol for a randomised controlled trial of the clinical and cost-effectiveness of the STAMINA lifestyle intervention compared with optimised usual care, including internal pilot and parallel process evaluation.
McNaught E, Reale S, Bourke L, Brown JE, Collinson M, Day F, Hewison J, Farrin AJ, Ibeggazene S, Innes AQ, Mason E, Meads D, Scope A, Taylor C, Taylor SJ, Turner RR, Rosario DJ; STAMINA co-investigators. McNaught E, et al. Among authors: hewison j. Trials. 2024 Apr 12;25(1):257. doi: 10.1186/s13063-024-07989-y. Trials. 2024. PMID: 38610058 Free PMC article.
Fixing the Leaky Pipe: How to Improve the Uptake of Patient-Reported Outcomes-Based Prognostic and Predictive Models in Cancer Clinical Practice.
Spencer KL, Absolom KL, Allsop MJ, Relton SD, Pearce J, Liao K, Naseer S, Salako O, Howdon D, Hewison J, Velikova G, Faivre-Finn C, Bekker HL, van der Veer SN. Spencer KL, et al. Among authors: hewison j. JCO Clin Cancer Inform. 2023 Sep;7:e2300070. doi: 10.1200/CCI.23.00070. JCO Clin Cancer Inform. 2023. PMID: 37976441 Free article.
An intervention to support stroke survivors and their carers in the longer term: results of a cluster randomised controlled feasibility trial (LoTS2Care).
Forster A, Ozer S, Brindle R, Barnard L, Hardicre N, Crocker TF, Chenery M, Moreau L, Wright A, Burton LJ, Hartley S, Hulme C, Dawkins B, Holloway I, House A, Hewison J, Farrin A; LoTS2Care Programme Team. Forster A, et al. Among authors: hewison j. Pilot Feasibility Stud. 2023 Mar 15;9(1):40. doi: 10.1186/s40814-023-01258-6. Pilot Feasibility Stud. 2023. PMID: 36922866 Free PMC article.
The Prehabilitation Radiotherapy Exercise, smoking Habit cessation and Balanced diet Study (PREHABS) protocol to explore the feasibility of embedding behavioural modifications into the clinical pathway for patients undergoing radical radiotherapy for lung cancer.
Burnett C, Bestall J, Boland A, Burke S, Callister M, Greenwood-Wilson S, Hewison J, Morgan E, Murray RL, Pompili C, Sloss A, Williams G, Franks K. Burnett C, et al. Among authors: hewison j. BMJ Open. 2024 Jan 25;14(1):e081365. doi: 10.1136/bmjopen-2023-081365. BMJ Open. 2024. PMID: 38272548 Free PMC article.
Cost-Effectiveness of eRAPID eHealth Intervention for Symptom Management During Chemotherapy.
Dawkins B, Absolom K, Hewison J, Warrington L, Hudson E, Holch P, Carter R, Gibson A, Holmes M, Rogers Z, Dickinson S, Morris C, Woroncow B, Brown J, Hulme C, Velikova G. Dawkins B, et al. Among authors: hewison j. JCO Oncol Pract. 2024 Apr;20(4):581-590. doi: 10.1200/OP.23.00498. Epub 2024 Jan 24. JCO Oncol Pract. 2024. PMID: 38266205 Free article. Clinical Trial.
Experience of an NIHR Clinical Lectureship (medical/dental) and the determining factors for a clinical academic career post lectureship: a mixed-method evaluation.
Stevenson CJ, Harris-Joseph H, Harper L, Hewison J, Mulvey MR, Heuvelman H, McVicker C, Razalan MM, Knowles E, Ebanks B, Lee K, Fenton J, Thompson P, Cotterill LA. Stevenson CJ, et al. Among authors: hewison j. BMJ Open. 2023 Nov 17;13(11):e070536. doi: 10.1136/bmjopen-2022-070536. BMJ Open. 2023. PMID: 37977870 Free PMC article.
Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial.
Brown JE, Royle KL, Gregory W, Ralph C, Maraveyas A, Din O, Eisen T, Nathan P, Powles T, Griffiths R, Jones R, Vasudev N, Wheater M, Hamid A, Waddell T, McMenemin R, Patel P, Larkin J, Faust G, Martin A, Swain J, Bestall J, McCabe C, Meads D, Goh V, Min Wah T, Brown J, Hewison J, Selby P, Collinson F; STAR Investigators. Brown JE, et al. Among authors: hewison j. Lancet Oncol. 2023 Mar;24(3):213-227. doi: 10.1016/S1470-2045(22)00793-8. Epub 2023 Feb 13. Lancet Oncol. 2023. PMID: 36796394 Free article. Clinical Trial.
155 results